The results of the CTG assay were very similar and showed that the two GA and CP-1 and CP-2 did not adversely affect the differentiated neuroblastoma cells, but treatment with CP-3 reduced the viability of the cells at both concentrations tested (Fig 4B). Here, CP is linked to neuroblastoma.